Annotations: 4DVY

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A [auth P]	PF18971	e4dvyP1	A: alpha bundles	X: Oncogenic effector CagA N-terminal domain (From Topology)	H: Oncogenic effector CagA N-terminal domain (From Topology)	T: Oncogenic effector CagA N-terminal domain	F: PF18971	ECOD (1.6)
A [auth P]	PF18971	e4dvyP3	A: alpha bundles	X: Oncogenic effector CagA domain III (From Topology)	H: Oncogenic effector CagA domain III (From Topology)	T: Oncogenic effector CagA domain III	F: PF18971	ECOD (1.6)
A [auth P]	PF18971	e4dvyP2	A: a+b complex topology	X: Oncogenic effector CagA meander beta sheet domain (From Topology)	H: Oncogenic effector CagA meander beta sheet domain (From Topology)	T: Oncogenic effector CagA meander beta sheet domain	F: PF18971	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A [auth P]	1.10.357.130	Mainly Alpha	Orthogonal Bundle	Tetracycline Repressor	domain 2	CATH (4.3.0)
A [auth P]	1.20.120.1270	Mainly Alpha	Up-down Bundle	Four Helix Bundle (Hemerythrin (Met), subunit A)	CagA exotoxin domain III	CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A [auth P]	PF18971	CagA protein (CagA_N)	CagA protein	-	Family

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A [auth P]	Cytotoxicity-associated immunodominant antigen	toxin transmembrane transporter activity transporter activity transmembrane transporter activity molecular adaptor activity	-	-

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A [auth P]	IPR045157	CagA, N-terminal	Domain
A [auth P]	IPR005169	CagA exotoxin, phosphopeptide substrate mimic region	Domain
A [auth P]	IPR004355	Type IV secretion system CagA exotoxin	Family

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.